Cargando…

Coping with drug resistant tuberculosis alongside COVID-19 and other stressors in Zimbabwe: a qualitative study

BACKGROUND: Households in low-resource settings are more vulnerable to events which adversely affect their livelihoods, including shocks such as the death of a family member, inflation, droughts and more recently COVID-19. Drug Resistant Tuberculosis (DR-TB) is also another shock that inflicts physi...

Descripción completa

Detalles Bibliográficos
Autores principales: Timire, Collins, Kranzer, Katharina, Pedrazzoli, Debora, Kavenga, Fungai, Kasozi, Samuel, Mbiba, Fredrick, Bond, Virginia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10002793/
https://www.ncbi.nlm.nih.gov/pubmed/36909482
http://dx.doi.org/10.1101/2023.02.24.23286187
_version_ 1784904461794148352
author Timire, Collins
Kranzer, Katharina
Pedrazzoli, Debora
Kavenga, Fungai
Kasozi, Samuel
Mbiba, Fredrick
Bond, Virginia
author_facet Timire, Collins
Kranzer, Katharina
Pedrazzoli, Debora
Kavenga, Fungai
Kasozi, Samuel
Mbiba, Fredrick
Bond, Virginia
author_sort Timire, Collins
collection PubMed
description BACKGROUND: Households in low-resource settings are more vulnerable to events which adversely affect their livelihoods, including shocks such as the death of a family member, inflation, droughts and more recently COVID-19. Drug Resistant Tuberculosis (DR-TB) is also another shock that inflicts physical, psychological and socioeconomic burden on individuals and households. We describe experiences and coping strategies among people affected by DR-TB and their households in Zimbabwe during the COVID-19 pandemic, 2020 to 2021. METHODS: We conducted 16 in-depth interviews with adults who had just completed or were completing treatment. Interview themes included health seeking behaviour, impact of DR-TB on livelihoods and coping strategies adopted during treatment. We analysed data using thematic analyses. RESULTS: Health seeking from providers outside the public sector, extra-pulmonary TB and health system factors resulted in delayed DR-TB diagnosis and treatment and increased financial drain on households. DR-TB reduced productive capacity and narrowed job opportunities leading to income loss that continued even after completion of treatment. Household livelihood was further adversely affected by lockdowns due to COVID-19, outbreaks of bird flu and cattle disease. Stockouts of DR-TB medicines, common during COVID-19, exacerbated loss of productive time and transport costs as medication had to be accessed from other clinics that were further away. Reversible coping strategies included: reducing number of meals; relocating in search of caregivers and/or family support; spending savings; negotiating with school authorities to keep children in school. Some households had to adopt irreversible coping strategies such as selling productive assets and withdrawing children from school. CONCLUSION: DR-TB combined with COVID-19 and other stressors pushed households into deeper poverty, and vulnerability. Multi-sectoral approaches that combine health systems, psychosocial and economic interventions are crucial to mitigate diagnostic delays and suffering, and meaningfully support people with DR-TB and their households to compensate the loss of livelihoods during and post DR-TB treatment.
format Online
Article
Text
id pubmed-10002793
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Cold Spring Harbor Laboratory
record_format MEDLINE/PubMed
spelling pubmed-100027932023-03-11 Coping with drug resistant tuberculosis alongside COVID-19 and other stressors in Zimbabwe: a qualitative study Timire, Collins Kranzer, Katharina Pedrazzoli, Debora Kavenga, Fungai Kasozi, Samuel Mbiba, Fredrick Bond, Virginia medRxiv Article BACKGROUND: Households in low-resource settings are more vulnerable to events which adversely affect their livelihoods, including shocks such as the death of a family member, inflation, droughts and more recently COVID-19. Drug Resistant Tuberculosis (DR-TB) is also another shock that inflicts physical, psychological and socioeconomic burden on individuals and households. We describe experiences and coping strategies among people affected by DR-TB and their households in Zimbabwe during the COVID-19 pandemic, 2020 to 2021. METHODS: We conducted 16 in-depth interviews with adults who had just completed or were completing treatment. Interview themes included health seeking behaviour, impact of DR-TB on livelihoods and coping strategies adopted during treatment. We analysed data using thematic analyses. RESULTS: Health seeking from providers outside the public sector, extra-pulmonary TB and health system factors resulted in delayed DR-TB diagnosis and treatment and increased financial drain on households. DR-TB reduced productive capacity and narrowed job opportunities leading to income loss that continued even after completion of treatment. Household livelihood was further adversely affected by lockdowns due to COVID-19, outbreaks of bird flu and cattle disease. Stockouts of DR-TB medicines, common during COVID-19, exacerbated loss of productive time and transport costs as medication had to be accessed from other clinics that were further away. Reversible coping strategies included: reducing number of meals; relocating in search of caregivers and/or family support; spending savings; negotiating with school authorities to keep children in school. Some households had to adopt irreversible coping strategies such as selling productive assets and withdrawing children from school. CONCLUSION: DR-TB combined with COVID-19 and other stressors pushed households into deeper poverty, and vulnerability. Multi-sectoral approaches that combine health systems, psychosocial and economic interventions are crucial to mitigate diagnostic delays and suffering, and meaningfully support people with DR-TB and their households to compensate the loss of livelihoods during and post DR-TB treatment. Cold Spring Harbor Laboratory 2023-02-27 /pmc/articles/PMC10002793/ /pubmed/36909482 http://dx.doi.org/10.1101/2023.02.24.23286187 Text en https://creativecommons.org/licenses/by-nc-nd/4.0/This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which allows reusers to copy and distribute the material in any medium or format in unadapted form only, for noncommercial purposes only, and only so long as attribution is given to the creator.
spellingShingle Article
Timire, Collins
Kranzer, Katharina
Pedrazzoli, Debora
Kavenga, Fungai
Kasozi, Samuel
Mbiba, Fredrick
Bond, Virginia
Coping with drug resistant tuberculosis alongside COVID-19 and other stressors in Zimbabwe: a qualitative study
title Coping with drug resistant tuberculosis alongside COVID-19 and other stressors in Zimbabwe: a qualitative study
title_full Coping with drug resistant tuberculosis alongside COVID-19 and other stressors in Zimbabwe: a qualitative study
title_fullStr Coping with drug resistant tuberculosis alongside COVID-19 and other stressors in Zimbabwe: a qualitative study
title_full_unstemmed Coping with drug resistant tuberculosis alongside COVID-19 and other stressors in Zimbabwe: a qualitative study
title_short Coping with drug resistant tuberculosis alongside COVID-19 and other stressors in Zimbabwe: a qualitative study
title_sort coping with drug resistant tuberculosis alongside covid-19 and other stressors in zimbabwe: a qualitative study
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10002793/
https://www.ncbi.nlm.nih.gov/pubmed/36909482
http://dx.doi.org/10.1101/2023.02.24.23286187
work_keys_str_mv AT timirecollins copingwithdrugresistanttuberculosisalongsidecovid19andotherstressorsinzimbabweaqualitativestudy
AT kranzerkatharina copingwithdrugresistanttuberculosisalongsidecovid19andotherstressorsinzimbabweaqualitativestudy
AT pedrazzolidebora copingwithdrugresistanttuberculosisalongsidecovid19andotherstressorsinzimbabweaqualitativestudy
AT kavengafungai copingwithdrugresistanttuberculosisalongsidecovid19andotherstressorsinzimbabweaqualitativestudy
AT kasozisamuel copingwithdrugresistanttuberculosisalongsidecovid19andotherstressorsinzimbabweaqualitativestudy
AT mbibafredrick copingwithdrugresistanttuberculosisalongsidecovid19andotherstressorsinzimbabweaqualitativestudy
AT bondvirginia copingwithdrugresistanttuberculosisalongsidecovid19andotherstressorsinzimbabweaqualitativestudy